Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction
- PMID: 35830096
- PMCID: PMC9352138
- DOI: 10.36660/abc.20210400
Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction
Abstract
Background: In Chronic Chagas Cardiomyopathy (CCC), studies are needed to identify arrhythmogenic risk factors in patients in which moderate to severe ventricular dysfunction is not present.
Objective: To verify the correlation between frequent ventricular arrhythmias (PVC), left ventricular ejection fraction (LVEF), extension of fibrosis by cardiac magnetic resonance (CMR), and urinary norepinephrine measurement (NOREPI) in CCC with preserved or mildly compromised LVEF.
Methods: The presence of ventricular extrasystoles > 30/h was analyzed on Holter. At CMR, LVEF and quantification of fibrosis mass were evaluated. The dosage of NOREPI was performed using the Muskiet method. The correlation coefficient matrix was calculated to measure the predictive ability of the variables to predict another variable, with p < 0.05 being considered significant.
Results: A total of 59 patients were included. The mean age was 57.9 + 10.94 years. PVC was detected in 28 patients. The fibrosis variable was inversely proportional to LVEF (R of -0.61) and NOREPI (R of -0.68). Also, the variable PVC was inversely proportional to LVEF (R of -0.33) and NOREPI (R of -0.27). On the other hand, LVEF was directly proportional to NOREPI (R of 0.83).
Conclusion: In this sample, in patients with CCC with preserved or slightly reduced LVEF, integrity of the autonomic nervous system is observed in hearts with little fibrosis and higher LVEF despite the presence of traditional risk factors for sudden cardiac death. There is correlation between the levels of NOREPI, LVEF, and myocardial fibrosis, but not with PVC.
Fundamento: Na cardiomiopatia chagásica crônica (CCC), impõem-se estudos com a proposta de identificar fatores de risco arritmogênicos em pacientes nos quais a disfunção ventricular de moderada a grave não está presente.
Objetivos: Verificar a dependência entre arritmias ventriculares frequentes (ARV), fração de ejeção de ventrículo esquerdo (FEVE), extensão da fibrose pela ressonância magnética cardíaca (RMC) e dosagem de norepinefrina urinária (NOREPI) na CCC com FEVE preservada ou minimamente comprometida.
Métodos: Foi analisada no Holter a presença de extrassístoles ventriculares >30/hora. Na RMC, avaliou-se a FEVE e a quantificação de massa fibrosada. Foi realizada a dosagem de NOREPI pelo método de Muskiet. A matriz de correlação foi calculada para aferir a capacidade de as variáveis preverem outra sendo considerado significante p<0,05.
Resultados: Foram incluídos no estudo 59 pacientes, com idade média de 57,9±10,94 anos. Arritmia ventricular frequente (ARV) foi detectada em 28 pacientes. A variável fibrose mostrou-se inversamente proporcional à fração de ejeção de ventrículo esquerdo (FEVE) (R de −0,61) e à norepinefrina urinária (NOREPI) (R de −0,68), assim como a variável ARV mostrou-se inversamente proporcional à FEVE (R de −0,33) e à NOREPI (R de −0,27). Já a FEVE mostrou-se diretamente proporcional à NOREPI (R de 0,83).
Conclusão: Nesta amostra, em pacientes com CCC com FEVE preservada ou discretamente reduzida, observa-se a integridade do sistema nervoso autonômico em corações com pouca fibrose e FEVE mais elevada, apesar da presença de tradicionais fatores de risco para morte súbita cardíaca. Há dependência entre os níveis de NOREPI, FEVE e fibrose miocárdica, mas não com ARV.
Conflict of interest statement
Não há conflito com o presente artigo.
Figures




Comment in
-
Chagas Heart Disease: The Evolution of the Disease and its Complementary Exams.Arq Bras Cardiol. 2022 Jul;119(1):12-13. doi: 10.36660/abc.20220418. Arq Bras Cardiol. 2022. PMID: 35830097 Free PMC article. English, Portuguese. No abstract available.
Similar articles
-
Electrocardiogram abnormalities in chronic Chagas cardiomyopathy correlate with scar mass and left ventricular dysfunction as assessed by cardiac magnetic resonance imaging.J Electrocardiol. 2022 May-Jun;72:66-71. doi: 10.1016/j.jelectrocard.2022.03.005. Epub 2022 Mar 21. J Electrocardiol. 2022. PMID: 35344746
-
Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction.Arq Bras Cardiol. 2014 May;102(5):456-64. doi: 10.5935/abc.20140052. Epub 2014 May 9. Arq Bras Cardiol. 2014. PMID: 24918912 Free PMC article.
-
Association of left ventricular abnormalities with incident cerebrovascular events and sources of thromboembolism in patients with chronic Chagas cardiomyopathy.J Cardiovasc Magn Reson. 2022 Nov 3;24(1):52. doi: 10.1186/s12968-022-00885-x. J Cardiovasc Magn Reson. 2022. PMID: 36329520 Free PMC article.
-
Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?Eur Heart J. 2013 Jul;34(26):1964-71. doi: 10.1093/eurheartj/eht109. Epub 2013 May 3. Eur Heart J. 2013. PMID: 23644180 Review.
-
Predictors of Left Ventricular Ejection Fraction Improvement after Radiofrequency Catheter Ablation in Patients with PVC-Induced Cardiomyopathy: A Systematic Review.Curr Cardiol Rev. 2020;16(4):315-325. doi: 10.2174/1573403X15666190710095248. Curr Cardiol Rev. 2020. PMID: 31288727 Free PMC article.
Cited by
-
Chagas Heart Disease: The Evolution of the Disease and its Complementary Exams.Arq Bras Cardiol. 2022 Jul;119(1):12-13. doi: 10.36660/abc.20220418. Arq Bras Cardiol. 2022. PMID: 35830097 Free PMC article. English, Portuguese. No abstract available.
References
-
- Martins-Melo FR, Ramos AN Jr, Alencar CH, Heukelbach J. Prevalence of Chagas Disease in Brazil: A Systematic Review and Meta-Analysis. Acta Trop. 2014;130:167-74. doi: 10.1016/j.actatropica.2013.10.002. - PubMed
-
- Dias JC, Prata A, Correia D. Problems and Perspectives for Chagas Disease Control: In Search of a Realistic Analysis. Rev Soc Bras Med Trop. 2008;41(2):193-6. doi: 10.1590/s0037-86822008000200012. - PubMed
-
- Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and Validation of a Risk Score for Predicting Death in Chagas’ Heart Disease. N Engl J Med. 2006;355(8):799-808. doi: 10.1056/NEJMoa053241. - PubMed
-
- Rassi A Jr, Rassi SG, Rassi A. Sudden Death in Chagas’ Disease. Arq Bras Cardiol. 2001;76(1):75-96. doi: 10.1590/s0066-782x2001000100008. - PubMed
-
- Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of chronic Chagas Heart Disease. Circulation. 2007 6;115(9):1109-23. doi: 10.1161/CIRCULATIONAHA.106.624296. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical